alkinnov.com
About company
In 2011, Alkion BioPharma has been created to revolutionize the secondary metabolims production for cancer therapies. Imperial Innovations, a team of Imperial College researchers and business professionals joined together to develop the technologies able to transform the non-GMO plants into a natural biorefinery. Quickly the technological platform received strong interests from the cosmetic community and the company signed research contracts to develop new disruptive cosmetic ingredients. Four years after inception, with a strong commercial pipeline, Alkion BioPharma has been acquired by Evonik Industries AG for cosmetic & food supplements applications. The new company Alkion BioInnovations was created in March 2017 in order to develop disruptive nutrition, non-cosmetic oil, and agrochemical solutions. The company owns exclusive rights on this applications.
